JPRN-UMIN000019011
Completed
未知
A Study on Predictors of Treatment Response to Sofosbuvir and Ledipasvir Therapy in Patients with genotype 1 Chronic Hepatitis C Virus Infection - Predictor of treatment response to SOF LDV therapy
Department of Gastroenterology and Hepatology, Graduate School of Medicine, Hokkaido University0 sites260 target enrollmentOctober 1, 2015
ConditionsPatients with genotype 1 HCV infection
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Patients with genotype 1 HCV infection
- Sponsor
- Department of Gastroenterology and Hepatology, Graduate School of Medicine, Hokkaido University
- Enrollment
- 260
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1 Patients with poorly controlled cardiac disease (myocardial infarction, cardiac failure, arrhythmia) 2 Patients with severe hepatic impairment 3 Patients with a history of hypersensitivity to HCV NS5B inhibitors or Ribavirin 4 Patients with a concurrent malignancy, including hepatocellular carcinoma, at the start of treatment 5 Patients deemed unsuitable for study entry by their treating physician 6 Patients with renal dysfunction 7 Patients who are unsuitable, in the opinion of the principal investigator, for this study due to any other reason
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A Study on Predictors of Treatment Response to Sofosbuvir and Ribavirin Therapy in Patients with genotype 2 Chronic Hepatitis C Virus InfectioPatients with genotype 2 HCV infectionJPRN-UMIN000018947Hokkaido University Department of Gastroenterology and Hepatology, Graduate School of Medicine,260
Not yet recruiting
Not Applicable
Treatment Efficacy and Outcome of treatment of Sofosbuvir/Velpatasvir in Hepatitis C Virus Infection Among Adolescents and Young Adultsadolescents and young adults who have hepatitis C virus infectionHepatitis C virus, adolescents, young adults, sofosbuvir/velpatasvir, efficacy, treatment outcomeTCTR20230610001Research and Developmeny Institute35
Completed
Not Applicable
A Study on Predictors of Treatment Response to ombitasvir/paritaprevir/r combination therapy in Patients with genotype 1 Chronic Hepatitis C Virus InfectioPatients with genotype 1 HCV infectionJPRN-UMIN000020299Hokkaido University260
Completed
Not Applicable
A Study on Predictors of Treatment Response to Simeprevir, Peg-interferon and Ribavirin combination therapyin Patients with genotype Chronic Hepatitis C Virus InfectioPatients with genotype 1 HCV infectionJPRN-UMIN000020295Hokkaido University200
Recruiting
Not Applicable
A prospective study of treatment response of patients with myelofibrosis and PNH type blood cellsmyelofibrosisJPRN-UMIN000045859Juntendo University100